IJDVL Home  
 

ORIGINAL CONTRIBUTION
[Download PDF]  
Year : 1988  |  Volume : 54  |  Issue : 1  |  Page : 27-29

Evaluation Of-astemizole- A New H-1 Blocking Antihistamine in Urticaria

JS Pasricha1, Anil Dashore2, RK Arya3 
1 
2 
3 

Correspondence Address:

An open trial of astemizole a new anthistamine on 30 patients, having urticaria revealed complete relief in 28 patients. The controlling daily dose was 10 mg in 17 patients, 20 mg in 7 and 30 mg in 4. Two patients did not improve even with 40 mg a day given for 7 days. The side effects included mild sedation in 7, dryness of mouth in 3 and constipation in 2 on a dose of 20 or 30 mg a day. Laboratory parameters remained almost normal.


How to cite this article:
Pasricha J S, Dashore A, Arya R K. Evaluation Of-astemizole- A New H-1 Blocking Antihistamine in Urticaria.Indian J Dermatol Venereol Leprol 1988;54:27-29


How to cite this URL:
Pasricha J S, Dashore A, Arya R K. Evaluation Of-astemizole- A New H-1 Blocking Antihistamine in Urticaria. Indian J Dermatol Venereol Leprol [serial online] 1988 [cited 2019 Aug 25 ];54:27-29
Available from: http://www.ijdvl.com/article.asp?issn=0378-6323;year=1988;volume=54;issue=1;spage=27;epage=29;aulast=Pasricha;type=0


 

Sunday, August 25, 2019
 Site Map | Home | Contact Us | Feedback | Copyright and disclaimer